Plasma <scp>PlGF</scp> as a Potential Biomarker in Ramucirumab‐Based Second‐Line Therapy for Advanced Gastroesophageal Adenocarcinoma: Exploratory Biomarker Analysis from the Phase <scp>II</scp> Part of the <scp>RAMIRIS</scp> Trial

Jurek Hille, Sylvie Lorenzen, Claudia Pauligk, Victoria Gensch, Peter Thuss‐Patience, Eray Goekkurt, Thomas Ettrich, Florian Lordick, Carsten Bokemeyer, Christian Müller, Peter Reichardt, Martin Sökler, Daniel Pink, Stefan Probst, Thorsten O. Goetze, Salah E. Al‐Batran, Sonja Loges, Melanie Janning

Open source

DOI: 10.1002/ijc.70567
Published: 2026-06-09
Container: International Journal of Cancer
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/ijc.70567,
  title = {Plasma
                    <scp>PlGF</scp>
                    as a Potential Biomarker in Ramucirumab‐Based Second‐Line Therapy for Advanced Gastroesophageal Adenocarcinoma: Exploratory Biomarker Analysis from the Phase
                    <scp>II</scp>
                    Part of the
                    <scp>RAMIRIS</scp>
                    Trial},
  author = {Jurek Hille and Sylvie Lorenzen and Claudia Pauligk and Victoria Gensch and Peter Thuss‐Patience and Eray Goekkurt and Thomas Ettrich and Florian Lordick and Carsten Bokemeyer and Christian Müller and Peter Reichardt and Martin Sökler and Daniel Pink and Stefan Probst and Thorsten O. Goetze and Salah E. Al‐Batran and Sonja Loges and Melanie Janning},
  year = {2026},
  journal = {International Journal of Cancer},
  doi = {10.1002/ijc.70567},
  url = {https://doi.org/10.1002/ijc.70567}
}

RIS

TY  - JOUR
TI  - Plasma
                    <scp>PlGF</scp>
                    as a Potential Biomarker in Ramucirumab‐Based Second‐Line Therapy for Advanced Gastroesophageal Adenocarcinoma: Exploratory Biomarker Analysis from the Phase
                    <scp>II</scp>
                    Part of the
                    <scp>RAMIRIS</scp>
                    Trial
AU  - Jurek Hille
AU  - Sylvie Lorenzen
AU  - Claudia Pauligk
AU  - Victoria Gensch
AU  - Peter Thuss‐Patience
AU  - Eray Goekkurt
AU  - Thomas Ettrich
AU  - Florian Lordick
AU  - Carsten Bokemeyer
AU  - Christian Müller
AU  - Peter Reichardt
AU  - Martin Sökler
AU  - Daniel Pink
AU  - Stefan Probst
AU  - Thorsten O. Goetze
AU  - Salah E. Al‐Batran
AU  - Sonja Loges
AU  - Melanie Janning
PY  - 2026
JO  - International Journal of Cancer
DO  - 10.1002/ijc.70567
UR  - https://doi.org/10.1002/ijc.70567
ER  -

APA

Hille, J., Lorenzen, S., Pauligk, C., Gensch, V., Thuss‐Patience, P., Goekkurt, E., Ettrich, T., Lordick, F., Bokemeyer, C., Müller, C., Reichardt, P., Sökler, M., Pink, D., Probst, S., Goetze, T. O., Al‐Batran, S. E., Loges, S., & Janning, M. (2026). Plasma <scp>PlGF</scp> as a Potential Biomarker in Ramucirumab‐Based Second‐Line Therapy for Advanced Gastroesophageal Adenocarcinoma: Exploratory Biomarker Analysis from the Phase <scp>II</scp> Part of the <scp>RAMIRIS</scp> Trial. International Journal of Cancer. https://doi.org/10.1002/ijc.70567

Source records

crossref · retrieved 2026-09-26T03:38:38.365Z